Blockchain Registration Transaction Record

Aclarion Showcases Pain-Detection Tech at Investor Conference

Aclarion to present at ROTH Conference, highlighting Nociscan tech for chronic back pain diagnosis. CEO discusses expansion plans and strong financial position.

Chronic low back pain is a leading cause of disability worldwide, often leading to invasive diagnostic procedures and treatments with mixed results due to difficulty pinpointing the exact source of pain. Aclarion's Nociscan technology represents a significant advancement in noninvasive diagnostics. By providing objective, biomarker-based data to help distinguish painful from nonpainful spinal discs, it could reduce diagnostic uncertainty, help avoid unnecessary surgeries, and enable more targeted, effective treatment plans. For patients, this means a potential path to more accurate diagnoses and better outcomes. For the healthcare system, it could lead to more efficient use of resources and reduced costs associated with chronic pain management. The company's participation in a major investor conference highlights its growth phase and the potential for this technology to scale, impacting how back pain is diagnosed and treated globally.